Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Apellis Pharmaceuticals Inc COM | 2,806,980 | 2,880,880 | +73,900 | $164.99M | $110.51M | 18.23% | -$54.48M |
| Dianthus Therapeutics, Inc.(DNTH) | 1,380,667 | 1,746,667 | +366,000 | $41.42M | $45.20M | 7.46% | +$3.78M |
| Structure Therapeutics IncADS | 506,604 | 1,140,060 | +633,456 | $21.71M | $44.77M | 7.39% | +$23.06M |
| Insmed Incorporated(INSM) | 1,140,000 | 650,216 | -489,784 | $30.93M | $43.56M | 7.19% | +$12.64M |
| Dyne Therapeutics, Inc.(DYN) | 1,242,945 | 1,180,798 | -62,147 | $35.29M | $41.67M | 6.88% | +$6.38M |
| ArriVent BioPharma, Inc.(AVBP) | 1,943,836 | 1,803,304 | -140,532 | $34.72M | $33.45M | 5.52% | -$1.27M |
| Verona Pharma PlcADS | 2,369,000 | 1,895,200 | -473,800 | $38.12M | $27.40M | 4.52% | -$10.71M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 405,000 | 488,000 | +83,000 | $15.89M | $22.08M | 3.64% | +$6.19M |
| Centessa Pharmaceuticals PlcADS | 2,060,100 | 2,345,075 | +284,975 | $23.28M | $21.18M | 3.49% | -$2.10M |
| BridgeBio Pharma, Inc.(BBIO) | 690,000 | 690,000 | 0 | $21.33M | $17.48M | 2.88% | -$3.86M |
| Ocular Therapeutix, Inc.(OCUL) | 2,425,000 | 2,425,000 | 0 | $22.07M | $16.59M | 2.74% | -$5.48M |
| Perspective Therapeutics, Inc.(CATX) | 0 | 1,580,249 | +1,580,249 | $0 | $15.76M | 2.60% | +$15.76M |
| Mind Medicine Mindmed Inc | 2,153,000 | 2,153,000 | 0 | $20.24M | $15.52M | 2.56% | -$4.72M |
| Praxis Precision Medicines, Inc.(PRAX) | 260,000 | 260,000 | 0 | $15.87M | $10.75M | 1.77% | -$5.11M |
| Taysha Gene Therapies, Inc.(TSHA) | 3,030,000 | 4,572,222 | +1,542,222 | $8.70M | $10.24M | 1.69% | +$1.55M |
| EyePoint, Inc.(EYPT) | 1,093,503 | 1,093,503 | 0 | $22.60M | $9.51M | 1.57% | -$13.09M |
| Terns Pharmaceuticals Inc | 625,000 | 1,364,400 | +739,400 | $4.10M | $9.29M | 1.53% | +$5.19M |
| Gossamer Bio, Inc.(GOSS) | 9,187,883 | 9,187,883 | 0 | $10.84M | $8.28M | 1.37% | -$2.56M |
| Viridian Therapeutics, Inc.(VRDN) | 620,000 | 620,000 | 0 | $10.86M | $8.07M | 1.33% | -$2.79M |
| Tenaya Therapeutics, Inc.(TNYA) | 2,854,000 | 2,576,200 | -277,800 | $14.93M | $7.99M | 1.32% | -$6.94M |
| Regulus Therapeutics Inc | 0 | 4,263,701 | +4,263,701 | $0 | $7.61M | 1.26% | +$7.61M |
| Allovir Inc | 4,200,000 | 9,800,000 | +5,600,000 | $3.17M | $7.09M | 1.17% | +$3.92M |
| Mineralys Therapeutics, Inc.(MLYS) | 550,000 | 600,000 | +50,000 | $7.10M | $7.02M | 1.16% | -$80.5K |
| An2 Therapeutics Inc | 1,103,000 | 3,220,263 | +2,117,263 | $3.58M | $6.92M | 1.14% | +$3.34M |
| Akero Therapeutics Inc | 340,000 | 283,372 | -56,628 | $8.59M | $6.65M | 1.10% | -$1.94M |
| Jasper Therapeutics, Inc.(JSPR) | 500,811 | 287,500 | -213,311 | $14.70M | $6.53M | 1.08% | -$8.18M |
| PepGen Inc.(PEPG) | 376,117 | 376,117 | 0 | $5.53M | $6.00M | 0.99% | +$473.9K |
| Ventyx Biosciences Inc | 1,501,114 | 2,391,114 | +890,000 | $8.26M | $5.52M | 0.91% | -$2.73M |
| Cybin D/B/A Helus Pharma(HELP) | 18,604,650 | 18,604,650 | 0 | $7.69M | $5.04M | 0.83% | -$2.65M |
| Century Therapeutics, Inc.(IPSC) | 540,000 | 1,333,650 | +793,650 | $2.26M | $3.40M | 0.56% | +$1.14M |
| Reneo Pharmaceuticals Inc | 2,250,000 | 2,250,000 | 0 | $3.73M | $3.40M | 0.56% | -$337.5K |
| Silence Therapeutics plcADS(SLN) | 315,000 | 176,000 | -139,000 | $6.80M | $3.34M | 0.55% | -$3.46M |
| Helix Acquisition Corp IiCL A | 250,000 | 250,000 | 0 | $2.59M | $2.56M | 0.42% | -$32.5K |
| Poseida Therapeutics Inc | 736,000 | 736,000 | 0 | $2.35M | $2.15M | 0.35% | -$198.7K |
| Elevation Oncology Inc | 0 | 747,000 | +747,000 | $0 | $2.02M | 0.33% | +$2.02M |
| Mersana Therapeutics Inc | 1,000,000 | 992,000 | -8,000 | $4.48M | $1.99M | 0.33% | -$2.49M |
| Annexon, Inc.(ANNX) | 2,050,000 | 400,000 | -1,650,000 | $14.70M | $1.96M | 0.32% | -$12.74M |
| Fate Therapeutics, Inc.(FATE) | 520,800 | 520,800 | 0 | $3.82M | $1.71M | 0.28% | -$2.11M |
| Nkarta, Inc.(NKTX) | 240,000 | 240,000 | 0 | $2.59M | $1.42M | 0.23% | -$1.18M |
| Nuvation Bio Inc.CL A(NUVB) | 1,374,870 | 431,600 | -943,270 | $5.00M | $1.26M | 0.21% | -$3.74M |
| Adicet Bio Inc | 767,799 | 767,799 | 0 | $1.80M | $929.0K | 0.15% | -$875.3K |
| Rapt Therapeutics Inc | 292,000 | 292,000 | 0 | $2.62M | $890.6K | 0.15% | -$1.73M |
| Aerovate Therapeutics Inc | 403,685 | 465,440 | +61,755 | $11.94M | $772.6K | 0.13% | -$11.16M |
| Autolus Therapeutics plcADS(AUTL) | 176,000 | 176,000 | 0 | $1.12M | $612.5K | 0.10% | -$510.4K |
| Allogene Therapeutics Inc | 720,000 | 0 | -720,000 | $3.22M | $0 | — | -$3.22M |
| Alpine Immune Sciences Inc | 1,241,300 | 0 | -1,241,300 | $49.21M | $0 | — | -$49.21M |
| Anaptysbio Inc | 165,000 | 0 | -165,000 | $3.72M | $0 | — | -$3.72M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 250,000 | 0 | -250,000 | $7.15M | $0 | — | -$7.15M |
| Atyr Pharma Inc | 700,000 | 0 | -700,000 | $1.36M | $0 | — | -$1.36M |
| Cabaletta Bio, Inc.(CABA) | 52,000 | 0 | -52,000 | $887.1K | $0 | — | -$887.1K |
| Cytokinetics, Incorporated(CYTK) | 194,000 | 0 | -194,000 | $13.60M | $0 | — | -$13.60M |
| Glycomimetics Inc | 3,000,000 | 0 | -3,000,000 | $9.00M | $0 | — | -$9.00M |
| Immunovant, Inc.(IMVT) | 273,289 | 0 | -273,289 | $8.83M | $0 | — | -$8.83M |
| Newamsterdam Pharma Company ORDINARY SHARES | 408,000 | 0 | -408,000 | $9.65M | $0 | — | -$9.65M |
| Perspective Therapeutics, Inc.(CATX) | 14,718,422 | 0 | -14,718,422 | $17.51M | $0 | — | -$17.51M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 455,000 | 0 | -455,000 | $4.83M | $0 | — | -$4.83M |
| Sana Biotechnology, Inc.(SANA) | 360,800 | 0 | -360,800 | $3.61M | $0 | — | -$3.61M |
| Veru Inc.(VERU) | 3,800,000 | 0 | -3,800,000 | $2.66M | $0 | — | -$2.66M |
| Vincerx Pharma Inc | 1,000,000 | 0 | -1,000,000 | $5.06M | $0 | — | -$5.06M |